|Medicinal Group||Blood-activating analgesic medicinal|
Dried resin of Commiphora myrrha Engler (C. molmol Engler) or several other species of the same genus (Fam. Burseraceae)
|Nature and Flavors||pungent, bitter; neutral|
|Meridian Affinity||Liver, Heart, Spleen|
To activate blood to relieve pain, reduce swelling and promote tissue regeneration
Traumatic injuries, sores and ulcers, carbuncles; pain due to blood stasis
- The formulation of myrrh may be safe, well tolerated, and effective for treating fascioliasis.
- Myrrh proved to be safe and very effective in treatment of schistosomiasis haematobium and mansoni infections under field conditions.
Contraindicated in pregnancy or patient without blood stasis
- Massoud A, El Sisi S, Salama O, Massoud A. (2001). Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). Am J Trop Med Hyg. , 65(2):96-9.
- Abo-Madyan AA, Morsy TA, Motawea SM. (2004). Efficacy of Myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt. J Egypt Soc Parasitol. , 34(2):423-46.